Loading...
XNAS
AMIX
Market cap3mUSD
Jul 28, Last price  
1.31USD
1D
-5.76%
1Q
-48.22%
IPO
-74.81%
Name

Autonomix Medical Inc

Chart & Performance

D1W1MN
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
Net income
-15m
L+674.99%
-13,328,715-1,990,477-15,426,000
CFO
-7m
L+258.50%
-387,307-1,854,398-6,648,000

Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
IPO date
Jan 29, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFY
2024‑032023‑032022‑03
Income
Revenues
Cost of revenue
7,555
1,990
Unusual Expense (Income)
NOPBT
(7,555)
(1,990)
NOPBT Margin
Operating Taxes
(1,990)
Tax Rate
NOPAT
(7,555)
(477)
Net income
(15,426)
674.99%
(1,990)
-85.07%
Dividends
Dividend yield
Proceeds from repurchase of equity
13,706
675
BB yield
-481.63%
Debt
Debt current
Long-term debt
1,002
Deferred revenue
Other long-term liabilities
Net debt
(7,606)
(865)
Cash flow
Cash from operating activities
(6,648)
(1,854)
CAPEX
(19)
Cash from investing activities
(19)
Cash from financing activities
14,410
675
FCF
(7,577)
(477)
Balance
Cash
8,608
865
Long term investments
Excess cash
8,608
865
Stockholders' equity
(38,950)
(23,531)
Invested Capital
47,580
24,175
ROIC
ROCE
EV
Common stock shares outstanding
942
18,794
Price
3.02
 
Market cap
2,846
 
EV
(4,760)
EBITDA
(7,474)
(1,990)
EV/EBITDA
0.64
Interest
79
Interest/NOPBT